Diffusion Pharmaceuticals Inc. Uncategorized Contracts & Agreements

29 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Indemnification Agreement between CervoMed Inc. and each of its directors and officers
Diffusion Pharmaceuticals Inc.
Biotechnology
DE
2024
Form of Stock Option Award Agreement under 2018 Employee, Director and Consultant Equity Incentive Plan
Diffusion Pharmaceuticals Inc.
Biotechnology
IL
2024
Description of Securities of CervoMed Inc
Diffusion Pharmaceuticals Inc.
Biotechnology
2024
Specimen Stock Certificate
Diffusion Pharmaceuticals Inc.
Biotechnology
2024
Amendment, dated as of January 29, 2019, to Offer Letter, dated April 29, 2018, by and between EIP Pharma, Inc., and Kelly Blackburn
Diffusion Pharmaceuticals Inc.
Biotechnology
2023
Offer Letter, dated as of April 29, 2018, by and between EIP Pharma, Inc., and Kelly Blackburn
Diffusion Pharmaceuticals Inc.
Biotechnology
2023
Form of Lock-up Agreement, dated as of March 30, 2023
Diffusion Pharmaceuticals Inc.
Biotechnology
2023
Form of EIP Pharma, Inc. Stockholder Support Agreement, dated as of March 30, 2023
Diffusion Pharmaceuticals Inc.
Biotechnology
DE
2023
Engagement Letter, dated March 27, 2020, by and between the Company and H.C. Wainwright & Co. LLC
Diffusion Pharmaceuticals Inc.
Biotechnology
VA
2020
Description of Securities
Diffusion Pharmaceuticals Inc.
Biotechnology
2020
Engagement Letter, dated December 11, 2019, between the Company and H.C. Wainwright & Co., LLC
Diffusion Pharmaceuticals Inc.
Biotechnology
VA
2019
Engagement Letter, dated October 7, 2019, by and between Diffusion Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC
Diffusion Pharmaceuticals Inc.
Biotechnology
VA
2019
Engagement Letter, dated May 3, 2019, between the Company and H.C. Wainwright & Co., LLC
Diffusion Pharmaceuticals Inc.
Biotechnology
VA
2019
Option Agreement
Diffusion Pharmaceuticals Inc.
Biotechnology
2016
CONTINGENT VALUE RIGHTS AGREEMENT
Diffusion Pharmaceuticals Inc.
Biotechnology
DE
2016
PLAN OF CONVERSION OF RESTORGENEX CORPORATION A NEVADA CORPORATION INTO RESTORGENEX CORPORATION, A DELAWARE CORPORATION
Diffusion Pharmaceuticals Inc.
Biotechnology
NV
2015
RESIGNATION AGREEMENT
Diffusion Pharmaceuticals Inc.
Biotechnology
NY
2015
DEBT CONVERSION AGREEMENT
Diffusion Pharmaceuticals Inc.
Biotechnology
IL
2015
INDEPENDENT CONTRACTOR AGREEMENT
Diffusion Pharmaceuticals Inc.
Biotechnology
CA
2014
SISKEY CAPITAL, LLC 4521 Sharon Road, Suite 450 Charlotte, NC 28211
Diffusion Pharmaceuticals Inc.
Biotechnology
NC
2013
Stratus Media Group, Inc. 10% SECURED CONVERTIBLE PROMISSORYNOTE
Diffusion Pharmaceuticals Inc.
Biotechnology
NV
2013
Stratus Media Group, Inc. 10% SECURED CONVERTIBLE PROMISSORYNOTE
Diffusion Pharmaceuticals Inc.
Biotechnology
FL
2013
SUBLICENSE AGREEMENT
Diffusion Pharmaceuticals Inc.
Biotechnology
NY
2013
DEBT CONVERSION AGREEMENT
Diffusion Pharmaceuticals Inc.
Biotechnology
CA
2013
W I T N E S S E T H:
Diffusion Pharmaceuticals Inc.
Biotechnology
2011
STRATUS MEDIA GROUP, INC. 3 East De La Guerra Street, 2nd Floor Santa Barbara, California 93101 June 13, 2011
Diffusion Pharmaceuticals Inc.
Biotechnology
NJ
2011
STRATUS MEDIA GROUP, INC. CERTIFICATE OF DESIGNATIONS OF THE SERIES D10% CONVERTIBLE PREFERRED SHARES Pursuant to Section 78.195 of the General Corporation Law of the State of...
Diffusion Pharmaceuticals Inc.
Biotechnology
2011
STRATUS MEDIA GROUP, INC. CERTIFICATE OF DESIGNATIONS OF THE SERIES C10% CONVERTIBLE PREFERRED SHARES Pursuant to Section 78.195 of the General Corporation Law of the State of...
Diffusion Pharmaceuticals Inc.
Biotechnology
2011
STRATUS MEDIA GROUP, INC. CERTIFICATE OF DESIGNATIONS OF THE SERIES C 10% CONVERTIBLE PREFERRED SHARES Pursuant to Section 78.195 of the General Corporation Law of the State of...
Diffusion Pharmaceuticals Inc.
Biotechnology
2011